Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1957 1
1959 1
1961 1
1962 2
1964 2
1966 1
1967 3
1968 1
1969 1
1970 1
1971 3
1972 3
1973 5
1974 9
1975 6
1976 4
1977 3
1978 6
1979 7
1980 4
1981 2
1982 3
1983 4
1984 4
1985 6
1986 1
1987 2
1988 3
1989 3
1990 7
1991 8
1992 6
1993 4
1994 5
1995 6
1996 5
1997 9
1998 11
1999 18
2000 16
2001 14
2002 12
2003 13
2004 15
2005 21
2006 18
2007 20
2008 17
2009 25
2010 31
2011 35
2012 38
2013 37
2014 32
2015 27
2016 25
2017 37
2018 38
2019 44
2020 33
2021 46
2022 53
2023 41

Text availability

Article attribute

Article type

Publication date

Search Results

770 results

Results by year

Filters applied: . Clear all
Page 1
Thrombosis and Coagulopathy in COVID-19.
Gómez-Mesa JE, Galindo-Coral S, Montes MC, Muñoz Martin AJ. Gómez-Mesa JE, et al. Among authors: montes mc. Curr Probl Cardiol. 2021 Mar;46(3):100742. doi: 10.1016/j.cpcardiol.2020.100742. Epub 2020 Nov 2. Curr Probl Cardiol. 2021. PMID: 33243440 Free PMC article. Review.
RNA Splicing and Disease: Animal Models to Therapies.
Montes M, Sanford BL, Comiskey DF, Chandler DS. Montes M, et al. Trends Genet. 2019 Jan;35(1):68-87. doi: 10.1016/j.tig.2018.10.002. Epub 2018 Nov 19. Trends Genet. 2019. PMID: 30466729 Free PMC article. Review.
Atezolizumab plus bevacizumab versus lenvatinib for unresectable hepatocellular carcinoma: a large real-life worldwide population.
Casadei-Gardini A, Rimini M, Tada T, Suda G, Shimose S, Kudo M, Cheon J, Finkelmeier F, Lim HY, Rimassa L, Presa J, Masi G, Yoo C, Lonardi S, Tovoli F, Kumada T, Sakamoto N, Iwamoto H, Aoki T, Chon HJ, Himmelsbach V, Pressiani T, Montes M, Vivaldi C, Soldà C, Piscaglia F, Hiraoka A, Sho T, Niizeki T, Nishida N, Steup C, Iavarone M, Di Costanzo G, Marra F, Scartozzi M, Tamburini E, Cabibbo G, Foschi FG, Silletta M, Hirooka M, Kariyama K, Tani J, Atsukawa M, Takaguchi K, Itobayashi E, Fukunishi S, Tsuji K, Ishikawa T, Tajiri K, Ochi H, Yasuda S, Toyoda H, Ogawa C, Nishimura T, Hatanaka T, Kakizaki S, Shimada N, Kawata K, Tada F, Ohama H, Nouso K, Morishita A, Tsutsui A, Nagano T, Itokawa N, Okubo T, Arai T, Imai M, Kosaka H, Naganuma A, Koizumi Y, Nakamura S, Kaibori M, Iijima H, Hiasa Y, Burgio V, Persano M, Della Corte A, Ratti F, De Cobelli F, Aldrighetti L, Cascinu S, Cucchetti A. Casadei-Gardini A, et al. Among authors: montes m. Eur J Cancer. 2023 Feb;180:9-20. doi: 10.1016/j.ejca.2022.11.017. Epub 2022 Nov 25. Eur J Cancer. 2023. PMID: 36527976 Clinical Trial.
Effects of Oropharyngeal Exercises on Snoring: A Randomized Trial.
Ieto V, Kayamori F, Montes MI, Hirata RP, Gregório MG, Alencar AM, Drager LF, Genta PR, Lorenzi-Filho G. Ieto V, et al. Among authors: montes mi. Chest. 2015 Sep;148(3):683-691. doi: 10.1378/chest.14-2953. Chest. 2015. PMID: 25950418 Clinical Trial.
Survival outcomes from atezolizumab plus bevacizumab versus Lenvatinib in Child Pugh B unresectable hepatocellular carcinoma patients.
Rimini M, Persano M, Tada T, Suda G, Shimose S, Kudo M, Cheon J, Finkelmeier F, Lim HY, Presa J, Salani F, Lonardi S, Piscaglia F, Kumada T, Sakamoto N, Iwamoto H, Aoki T, Chon HJ, Himmelsbach V, Schirripa M, Montes M, Vivaldi C, Soldà C, Hiraoka A, Sho T, Niizeki T, Nishida N, Steup C, Hirooka M, Kariyama K, Tani J, Atsukawa M, Takaguchi K, Itobayashi E, Fukunishi S, Tsuji K, Ishikawa T, Tajiri K, Ochi H, Yasuda S, Toyoda H, Ogawa C, Nishimura T, Hatanaka T, Kakizaki S, Shimada N, Kawata K, Tada F, Ohama H, Nouso K, Morishita A, Tsutsui A, Nagano T, Itokawa N, Okubo T, Arai T, Imai M, Kosaka H, Naganuma A, Koizumi Y, Nakamura S, Kaibori M, Iijima H, Hiasa Y, Burgio V, Scartozzi M, Cascinu S, Casadei-Gardini A. Rimini M, et al. Among authors: montes m. J Cancer Res Clin Oncol. 2023 Aug;149(10):7565-7577. doi: 10.1007/s00432-023-04678-2. Epub 2023 Mar 28. J Cancer Res Clin Oncol. 2023. PMID: 36976353
When should pre-exposure prophylaxis against HIV be implemented in Spain?
Martín-Carbonero L, Montes ML. Martín-Carbonero L, et al. Among authors: montes ml. Rev Clin Esp (Barc). 2019 Oct;219(7):396-397. doi: 10.1016/j.rce.2019.03.010. Epub 2019 May 7. Rev Clin Esp (Barc). 2019. PMID: 31076086 English, Spanish. No abstract available.
Clinical outcomes with atezolizumab plus bevacizumab or lenvatinib in patients with hepatocellular carcinoma: a multicenter real-world study.
Persano M, Rimini M, Tada T, Suda G, Shimose S, Kudo M, Cheon J, Finkelmeier F, Lim HY, Rimassa L, Presa J, Masi G, Yoo C, Lonardi S, Tovoli F, Kumada T, Sakamoto N, Iwamoto H, Aoki T, Chon HJ, Himmelsbach V, Pressiani T, Kawaguchi T, Montes M, Vivaldi C, Soldà C, Piscaglia F, Hiraoka A, Sho T, Niizeki T, Nishida N, Steup C, Iavarone M, Di Costanzo G, Marra F, Scartozzi M, Tamburini E, Cabibbo G, Foschi FG, Silletta M, Hirooka M, Kariyama K, Tani J, Atsukawa M, Takaguchi K, Itobayashi E, Fukunishi S, Tsuji K, Ishikawa T, Tajiri K, Ochi H, Yasuda S, Toyoda H, Ogawa C, Nishimura T, Hatanaka T, Kakizaki S, Shimada N, Kawata K, Tada F, Ohama H, Nouso K, Morishita A, Tsutsui A, Nagano T, Itokawa N, Okubo T, Arai T, Imai M, Kosaka H, Naganuma A, Koizumi Y, Nakamura S, Kaibori M, Iijima H, Hiasa Y, Cammarota A, Burgio V, Cascinu S, Casadei-Gardini A. Persano M, et al. Among authors: montes m. J Cancer Res Clin Oncol. 2023 Aug;149(9):5591-5602. doi: 10.1007/s00432-022-04512-1. Epub 2022 Dec 13. J Cancer Res Clin Oncol. 2023. PMID: 36509984
Vulvar tumor in an infant.
Arredondo Montero J, Bronte Anaut M, Bardají Pascual C, Montes M. Arredondo Montero J, et al. Among authors: montes m. Pediatr Dermatol. 2022 Sep;39(5):E3-E4. doi: 10.1111/pde.15010. Pediatr Dermatol. 2022. PMID: 36206215 No abstract available.
8G modifications rewire tumoral microRNAs.
Montes M, Huarte M. Montes M, et al. Nat Cell Biol. 2023 Sep;25(9):1243-1244. doi: 10.1038/s41556-023-01179-9. Nat Cell Biol. 2023. PMID: 37696948 No abstract available.
Real-World Data for Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma: How Does Adherence to the IMbrave150 Trial Inclusion Criteria Impact Prognosis?
Rimini M, Persano M, Tada T, Suda G, Shimose S, Kudo M, Cheon J, Finkelmeier F, Lim HY, Presa J, Masi G, Yoo C, Lonardi S, Piscaglia F, Kumada T, Sakamoto N, Iwamoto H, Aoki T, Chon HJ, Himmelsbach V, Pressiani T, Montes M, Vivaldi C, Soldà C, Hiraoka A, Sho T, Niizeki T, Nishida N, Steup C, Hirooka M, Kariyama K, Tani J, Atsukawa M, Takaguchi K, Itobayashi E, Fukunishi S, Tsuji K, Ishikawa T, Tajiri K, Ochi H, Yasuda S, Toyoda H, Ogawa C, Nishimura T, Hatanaka T, Kakizaki S, Shimada N, Kawata K, Tada F, Ohama H, Nouso K, Morishita A, Tsutsui A, Nagano T, Itokawa N, Okubo T, Arai T, Imai M, Kosaka H, Naganuma A, Koizumi Y, Nakamura S, Kaibori M, Iijima H, Hiasa Y, Burgio V, Rimassa L, Scartozzi M, Cascinu S, Casadei-Gardini A. Rimini M, et al. Among authors: montes m. Target Oncol. 2023 Mar;18(2):221-233. doi: 10.1007/s11523-023-00953-x. Epub 2023 Mar 15. Target Oncol. 2023. PMID: 36920648
770 results